Your browser doesn't support javascript.
loading
Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study.
Geissler, Rene; Hauber, Ilona; Funk, Nancy; Richter, Annekatrin; Behrens, Martina; Renner, Ivonne; Chemnitz, Jan; Hofmann-Sieber, Helga; Baum, Heidi; van Lunzen, Jan; Boch, Jens; Hauber, Joachim; Behrens, Sven-Erik.
Afiliación
  • Geissler R; Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.
  • Hauber I; Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Funk N; Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.
  • Richter A; Institute of Biology, Department of Genetics, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.
  • Behrens M; Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.
  • Renner I; Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.
  • Chemnitz J; Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Hofmann-Sieber H; Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Baum H; Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.
  • van Lunzen J; Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany; University Medical Center Hamburg-Eppendorf, Infectious Diseases Unit, Hamburg, Germany.
  • Boch J; Institute of Biology, Department of Genetics, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany.
  • Hauber J; Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany.
  • Behrens SE; Institute of Biochemistry and Biotechnology, Section Microbial Biotechnology, Martin Luther University Halle-Wittenberg, Faculty of Life Sciences (NFI), Halle/Saale, Germany. Electronic address: sven.behrens@biochemtech.uni-halle.de.
Virology ; 486: 248-54, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26474371
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Activación Viral / Infecciones por VIH / VIH-1 Límite: Humans Idioma: En Revista: Virology Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Activación Viral / Infecciones por VIH / VIH-1 Límite: Humans Idioma: En Revista: Virology Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos